Merit Medical Systems, Inc. (NASDAQ: MMSI) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $5.1B. The Maz Rating grades it against the other companies in its sector.
Merit Medical Systems, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $84.49, Merit Medical Systems, Inc. trades at 31.5x trailing earnings, 3.2x sales and 2.9x book value, with an EV/EBITDA of 14.3. Over the last twelve months it generated about $1.6B of revenue and $161M of net income. It runs a gross margin of 49.4%, an operating margin of 13.5% and a net margin of 9.9%. It shows return on equity of 9.7%, return on invested capital of 6.2% and a free cash flow yield of 4.0%. On the balance sheet: a debt-to-equity ratio of 0.47 and a current ratio of 4.52. Over the past 52 weeks the share price ranged from $59.74 to $94.85, with a beta of 0.55.
Merit Medical Systems, Inc. does not currently pay a dividend.
16 Wall Street analyst ratings cover the stock: 12 Buy, 3 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Merit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum of diagnostic, therapeutic, and interventional procedures, primarily within the fields of cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two main divisions: Cardiovascular and Endoscopy. Its extensive product portfolio includes advanced solutions for diagnosing and treating conditions in peripheral vessels and organs, as well as a comprehensive suite of cardiac intervention products. The latter encompasses tools for vascular access, angiography, electrophysiology, cardiac rhythm management, fluid and hemodynamic monitoring, hemostasis, and various interventional therapies for heart-related ailments. Additionally, MMSI provides customized procedural solutions, offering critical care items, disinfection protection systems, specialized syringes, manifold kits, and tailored trays and packs. Their offerings further extend to coated tubes and wires, alongside sophisticated sensor components for microelectromechanical systems (MEMS). The company also features pulmonary products, such as laser-cut tracheobronchial stents with their accompanying over-the-wire and direct visualization delivery systems, and dilation balloons used for endoscopic stricture dilation. Gastroenterology products, as well as essential kits and accessories for endoscopy and bronchoscopy procedures, complete their diverse catalog. Merit Medical Systems sells its products to a wide client base, including hospitals and healthcare professionals (physicians, technicians, and nurses) working in alternative care settings. Distribution channels include a direct sales force, authorized distributors, original equipment manufacturer (OEM) partnerships, and custom procedure tray manufacturers, reaching customers throughout the United States and internationally. Founded in 1987, Merit Medical Systems, Inc. has its corporate headquarters situated in South Jordan, Utah.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
Yes. As of September 2026, Merit Medical Systems, Inc. (MMSI) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 14.0% / 30% · (Cash+Inv) / Mkt Cap (36m) 9.54% / 30% · Interest income / Revenue 0.99% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 14.0% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 9.54% / 33% · Receivables / Mkt Cap (36m) 4.92% / 49% · Interest income / Revenue 0.99% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 14.0% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 9.54% / 33.33% · Receivables / Mkt Cap (24m) 4.92% / 33.33% · Interest income / Revenue 0.99% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 27.1% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 16.9% / 33.33% · Receivables / Avg Assets (4Q) 8.59% / 33.33% · Interest income / Revenue 0.99% / 5% | Pass |
| FTSE | Debt / Total Assets 25.2% / 33.33% · (Cash+ST Inv) / Total Assets 17.2% / 33.33% · (Cash+Recv) / Total Assets 26.1% / 33.33% · Interest income / Revenue 0.99% / 5% | Pass |
Yes. As of September 2026, Merit Medical Systems, Inc. (MMSI) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
Yes. Merit Medical Systems, Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 0.99% of each dividend: Merit Medical Systems, Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.